This is a prospective, within-subject controlled study involving simultaneous dual placement of wireless Bravo pH probes in each participant. Patients will receive pH testing when symptomatic for gastroesophageal reflux disease (GERD) to confirm diagnosis as part of standard of care. Each test is 96 hours with a symptom diary, GERD-HRQL, and RSI collected, which is also standard of care for patients presenting with GERD symptoms.
Inclusion Criteria:
Exclusion Criteria:
yvigneswaran@bsd.uchicago.edu773-702-6337
Each participant will undergo one Bravo pH monitoring sessions with two simultaneous probes placed Standard Bravo probe placed 6 cm above SCJ as standard of care. Experimental Bravo probe placed 1 cm above SCJ at the same time of standard of care procedure
Guadalupe.Castro@bsd.uchicago.edu773-834-6122
Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance (Encore)
An Assessment of pH Testing Methods
Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance
Correlations Between Wireless pH Monitoring and Variation in Reflux Symptom Questionnaire, 7 Day Recall
Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease
Usefulness of Wireless pH Monitoring in GERD Diagnosis
A Prospective, Observational Study of the PPI Non-responder
Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers